- Home
- IMCR vs IIPR Comparison
IMCR vs IIPR Comparison
Compare IMCR & IIPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IMCR
- IIPR
- Stock Information
- Founded
- IMCR 2008
- IIPR 2016
- Country
- IMCR United Kingdom
- IIPR United States
- Employees
- IMCR N/A
- IIPR N/A
- Industry
- IMCR Biotechnology: Biological Products (No Diagnostic Substances)
- IIPR Real Estate
- Sector
- IMCR Health Care
- IIPR Finance
- Exchange
- IMCR Nasdaq
- IIPR Nasdaq
- Market Cap
- IMCR 1.7B
- IIPR 1.5B
- IPO Year
- IMCR 2021
- IIPR 2016
- Fundamental
- Price
- IMCR $34.26
- IIPR $54.69
- Analyst Decision
- IMCR Buy
- IIPR Hold
- Analyst Count
- IMCR 9
- IIPR 8
- Target Price
- IMCR $57.00
- IIPR $88.75
- AVG Volume (30 Days)
- IMCR 287.1K
- IIPR 322.6K
- Earning Date
- IMCR 11-05-2025
- IIPR 11-05-2025
- Dividend Yield
- IMCR N/A
- IIPR 13.85%
- EPS Growth
- IMCR N/A
- IIPR N/A
- EPS
- IMCR N/A
- IIPR 4.63
- Revenue
- IMCR $356,145,000.00
- IIPR $287,883,000.00
- Revenue This Year
- IMCR $29.71
- IIPR N/A
- Revenue Next Year
- IMCR $11.27
- IIPR N/A
- P/E Ratio
- IMCR N/A
- IIPR $11.84
- Revenue Growth
- IMCR 26.78
- IIPR N/A
- 52 Week Low
- IMCR $23.15
- IIPR $45.44
- 52 Week High
- IMCR $39.33
- IIPR $136.81
- Technical
- Relative Strength Index (RSI)
- IMCR 49.34
- IIPR 48.42
- Support Level
- IMCR $33.92
- IIPR $51.96
- Resistance Level
- IMCR $37.00
- IIPR $58.10
- Average True Range (ATR)
- IMCR 1.45
- IIPR 1.68
- MACD
- IMCR -0.06
- IIPR -0.16
- Stochastic Oscillator
- IMCR 39.78
- IIPR 44.02
About IMCR Immunocore Holdings plc
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinical programs in autoimmune disease, and earlier pre-clinical programs across three therapeutic areas. The company's main product, KIMMTRAK, is used for the treatment of unresectable or metastatic uveal melanoma (mUM). The other drug candidates in its pipeline include Brenetafusp, IMC-P115C, IMC-T119C, IMC-R117C, IMC-S118AI, IMC-U120AI, and others, being developed as a potential treatment for various oncology, infectious, and autoimmune diseases.
About IIPR Innovative Industrial Properties Inc.
Innovative Industrial Properties Inc is a real estate investment trust engaged in the acquisition, ownership, and management of specialized industrial properties leased to state-licensed operators for their regulated medical-use cannabis facilities. It conducts its business through a traditional umbrella partnership real estate investment trust, or UPREIT structure, in which properties are owned by Operating Partnership, directly or through subsidiaries. Its property portfolio is spread across the United States.